“…Other ruthenium complexes have been previously reported as potent cytotoxic agents, including cyclometalated ruthenium β-carboline complexes, which were cytotoxic to lung, liver, breast, and cervical cancers [ 8 ]; piplartine-containing ruthenium complexes, which were cytotoxic to colon, tongue, liver, breast, skin, and hematological cancers [ 5 ]; a ruthenium complex with xanthoxylin, which was cytotoxic to colon, breast, liver, tongue, gastric, skin, and hematological cancers [ 9 ]; ruthenium imidazole complexes, which were cytotoxic to lung, liver, breast, and cervical cancers [ 19 ]; and, a ruthenium-based 5-fluorouracil complex, which had enhanced cytotoxicity to breast, colon, liver, tongue, skin, and hematological cancers [ 10 ]. The IC 50 values of these compounds are below 10 μM for most of the tested cancer cell lines.…”